Additive manufacturing is becoming an efficient and cost-effective alternative to traditional micro-manufacturing methods such as molding.

The company has seen major revenue loss since the pandemic began to wane, resulting in multiple layoffs.

Keeping you up to date on the latest medical device supplier news.

This is the second layoff announced by the company so far in 2024.

As Dexcom and Abbott both move closer to over-the-counter launches of continuous glucose monitoring sensors, analysts forecast revenue potential for the new category.

In the study, the device will be evaluated relative to technology that has already been FDA approved.